Showing results (31-40 of 68) with videos related to
Sort By:
Pageof 7
American Journal of Veterinary Research|August 23, 2005
In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in cats with lipopolysaccharide-induced pyrexiaMargaret E McCann, Eric L Rickes, Donald F Hora, et al.Bioorganic & Medicinal Chemistry Letters|November 3, 2010
Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas diseaseChristian Beaulieu, Elise Isabel, Angélique Fortier, et al.Antimicrobial Agents and Chemotherapy|December 11, 2013
Reversible cysteine protease inhibitors show promise for a Chagas disease cureMomar Ndao, Christian Beaulieu, W Cameron Black, et al.Journal of Medicinal Chemistry|November 24, 2005
Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivityJean-Pierre Falgueyret, Sylvie Desmarais, Renata Oballa, et al.Bioorganic & Medicinal Chemistry Letters|February 9, 2010
SAR and optimization of thiazole analogs as potent stearoyl-CoA desaturase inhibitorsYeeman K Ramtohul, Cameron Black, Chi-Chung Chan, et al.Cells|August 7, 2021
Short-Term Evaluation of Cellular Fate in an Ovine Bone Formation ModelHareklea Markides, Nicola C Foster, Jane S McLaren, et al.Analytical Biochemistry|November 24, 2004
An activity-based probe for the determination of cysteine cathepsin protease activities in whole cellsJean-Pierre Falgueyret, W Cameron Black, Wanda Cromlish, et al.Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438)Serge Léger, W Cameron Black, Denis Deschenes, et al.Biochemistry|September 14, 2002
Diversity in the oxidation of substrates by cytochrome P450 2D6: lack of an obligatory role of aspartate 301-substrate electrostatic bondingF Peter Guengerich, Grover P Miller, Imad H Hanna, et al.Bioorganic & Medicinal Chemistry Letters|August 30, 2011
Bicyclic heteroaryl inhibitors of stearoyl-CoA desaturase: from systemic to liver-targeting inhibitorsYeeman K Ramtohul, David Powell, Jean-Philippe Leclerc, et al.Pageof 7